Marla Kessler
Director/Board Member bei IRONWOOD PHARMACEUTICALS, INC.
Vermögen: 841 142 $ am 31.03.2024
Profil
Marla L.
Kessler is currently an Independent Director at Ironwood Pharmaceuticals, Inc. since 2019 and the Chief Marketing Officer at Datavant, Inc. since 2022.
Previously, she worked at IQVIA, Inc. from 2008 to 2020, where she held the position of Senior VP-Strategy, Marketing & Communications from 2016 to 2020.
She also served as the Chief Customer Officer at Aetion, Inc. from 2021 to 2022.
Ms. Kessler completed her undergraduate degree at Arizona State University and holds an MBA from The Fuqua School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.12.2023 | 96 572 ( 0,06% ) | 841 142 $ | 31.03.2024 |
Aktive Positionen von Marla Kessler
| Unternehmen | Position | Beginn |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Director/Board Member | 01.04.2019 |
Datavant, Inc.
 Datavant, Inc. Packaged SoftwareTechnology Services Datavant, Inc. focuses on employing artificial intelligence to improve the clinical trial process. It engages in the discovery, development, and commercialization of new medicines through machine learning. Datavant allows its customers to bring new therapies to patients faster, improve treatment plans, and reduce the cost of care. The company was founded by S. Travis May in 2017 and is headquartered in San Francisco, CA. | Sales & Marketing | 01.10.2022 |
Ehemalige bekannte Positionen von Marla Kessler
| Unternehmen | Position | Ende |
|---|---|---|
Aetion, Inc.
 Aetion, Inc. Packaged SoftwareTechnology Services Aetion, Inc. provides data analytics software solutions. The firm?s Aetion Evidence Platform enables life sciences customers to transform disparate data sets into evidence needed to make critical business decisions; and helps payers determine effective treatments for specific patient populations and measure impact in outcomes and utilization. The company was founded by Jeremy A. Rassen, Sebastian Schneeweiss and Allon Rauer in 2013 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.10.2022 |
| IMS HEALTH, INC. | Public Communications Contact | 01.10.2020 |
Ausbildung von Marla Kessler
| Arizona State University | Undergraduate Degree |
| The Fuqua School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
IQVIA, Inc.
 IQVIA, Inc. Data Processing ServicesTechnology Services IQVIA, Inc. provides information technology solutions to the healthcare industry. It offers research and development, enterprise information management, commercial analytics, market analysis, patient consent system, content management, and other related solutions. The company was founded by Bill Frohlich and David Dubow in 1954 and is headquartered in Danbury, CT. | Technology Services |
Aetion, Inc.
Aetion, Inc. Packaged SoftwareTechnology Services Aetion, Inc. provides data analytics software solutions. The firm?s Aetion Evidence Platform enables life sciences customers to transform disparate data sets into evidence needed to make critical business decisions; and helps payers determine effective treatments for specific patient populations and measure impact in outcomes and utilization. The company was founded by Jeremy A. Rassen, Sebastian Schneeweiss and Allon Rauer in 2013 and is headquartered in New York, NY. | Technology Services |
Datavant, Inc.
Datavant, Inc. Packaged SoftwareTechnology Services Datavant, Inc. focuses on employing artificial intelligence to improve the clinical trial process. It engages in the discovery, development, and commercialization of new medicines through machine learning. Datavant allows its customers to bring new therapies to patients faster, improve treatment plans, and reduce the cost of care. The company was founded by S. Travis May in 2017 and is headquartered in San Francisco, CA. | Technology Services |
